<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-vaccines-08-00306">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Didierlaurent</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Morel</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lockman</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Giannini</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Bisteau</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Carlsen</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kielland</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Vosters</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Vanderheyde</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Schiavetti</surname>
    <given-names>F.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>As04, an aluminum salt- and tlr4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity</article-title>
  <source>J. Immunol.</source>
  <year>2009</year>
  <volume>183</volume>
  <fpage>6186</fpage>
  <lpage>6197</lpage>
  <pub-id pub-id-type="doi">10.4049/jimmunol.0901474</pub-id>
  <?supplied-pmid 19864596?>
  <pub-id pub-id-type="pmid">19864596</pub-id>
 </element-citation>
</ref>
